Arkolith/Insider Trading/SER/Form 4

Moreadith Randall

Chief Scientific OfficerSerina Therapeutics, Inc. (SER) · full profile →Form 4 · filed Dec 4, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$23K
Net Open-Market Flow
-$23K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 3, 2025Sell(S)5K$3.52$18K0
Dec 3, 2025Option exercise(M)5K$0.06$3005K
Dec 2, 2025Sell(S)2K$3.91$6K0
Dec 2, 2025Option exercise(M)2K$0.06$902K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 3, 2025Option exercise(M)5K—$0372K
Dec 2, 2025Option exercise(M)2K—$0377K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001301120-25-000025) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML